Stocks › INCY
INCYTE CORP
INCY·Nasdaq·
United States·USD
$114.63
-1.25 (-1.07%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
INCY
INCYTE CORP · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
INCYS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of INCY by members of U.S. Congress · 42 on record · 6 in the last 12 months
Whale Activity
Position changes in INCY reported for 2026-09-30 by 979 institutional filers
- Increased359
- New130
- Held114
- Decreased258
- Closed74
- No prior filing44
| Filer | Shares | Value | Change |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 30.8M | $3.73B | increased |
| BlackRock, Inc. | 19.1M | $2.32B | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.2M | $1.36B | increased |
| DODGE & COX | 10.1M | $1.22B | decreased |
| STATE STREET CORP | 9.9M | $1.20B | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.8M | $943.3M | decreased |
| AQR CAPITAL MANAGEMENT LLC | 5.6M | $677.4M | increased |
| GEODE CAPITAL MANAGEMENT, LLC | 4.9M | $591.3M | increased |
| Invesco Ltd. | 4.1M | $502.0M | increased |
| LSV ASSET MANAGEMENT | 3.9M | $471.0M | — |
| WELLINGTON MANAGEMENT GROUP LLP | 3.4M | $407.8M | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 3.3M | $403.7M | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by INCY insiders, by quarter · Form 4
Recent Insider Transactions
2,717 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Stein Steven HCMO & Head of Late-Stage Dev. | Sale | −576 | $121.98 | $70K | Nov 16, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −877 | $121.98 | $107K | Nov 16, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −1,765 | $120.46 | $213K | Nov 16, 2026 | Form 4 ↗ |
| Heeson LeeEVP, Head of Incyte Intl | Sale | −874 | $121.16 | $106K | Nov 13, 2026 | Form 4 ↗ |
| Heeson LeeEVP, Head of Incyte Intl | Sale | −3,700 | $120.33 | $445K | Nov 13, 2026 | Form 4 ↗ |
| Heeson LeeEVP, Head of Incyte Intl | Sale | −2,449 | $121.13 | $297K | Nov 13, 2026 | Form 4 ↗ |
| Heeson LeeEVP, Head of Incyte Intl | Sale | −2,200 | $120.44 | $265K | Nov 13, 2026 | Form 4 ↗ |
| Heeson LeeEVP, Head of Incyte Intl | Sale | −1,471 | $121.89 | $179K | Nov 13, 2026 | Form 4 ↗ |
| Stein Steven HCMO & Head of Late-Stage Dev. | Sale | −74.0K | $119.12 | $8.8M | Nov 6, 2026 | Form 4 ↗ |
| Stein Steven HCMO & Head of Late-Stage Dev. | Sale | −60.3K | $118.27 | $7.1M | Nov 6, 2026 | Form 4 ↗ |
| Stein Steven HCMO & Head of Late-Stage Dev. | Sale | −48.6K | $119.66 | $5.8M | Nov 6, 2026 | Form 4 ↗ |
| Stein Steven HCMO & Head of Late-Stage Dev. | Sale | −35.0K | $116.06 | $4.1M | Nov 6, 2026 | Form 4 ↗ |
| Stein Steven HCMO & Head of Late-Stage Dev. | Sale | −22.3K | $117.14 | $2.6M | Nov 6, 2026 | Form 4 ↗ |
| Tray ThomasPrincipal Accounting Officer | Sale | −610 | $118.96 | $73K | Nov 3, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −2,642 | $112.71 | $298K | Oct 15, 2026 | Form 4 ↗ |
| Gardner David HEVP, Chief Strategy Officer | Tax withholding | −920 | $126.93 | $117K | Sep 22, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −14.0K | $120.49 | $1.7M | Sep 15, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Sale | −9,233 | $120.50 | $1.1M | Sep 15, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Option exercise | +9,233 | $71.93 | $664K | Sep 15, 2026 | Form 4 ↗ |
| CAGNONI PABLO JPresident, Global Head of R&D | Option exercise | +6,477 | $64.25 | $416K | Sep 15, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding INCY · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Dodge & Cox Stock Fund Dodge & Cox Funds | 8.0M | $901.6M | 0.76% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 5.4M | $611.1M | 0.03% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 4.3M | $492.8M | 0.03% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 3.9M | $441.5M | 0.23% | Jun 30, 2026 |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 2.4M | $285.2M | 0.75% | Jul 31, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 2.2M | $268.4M | 0.03% | Aug 31, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 2.3M | $261.8M | 0.03% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 2.2M | $254.6M | 0.54% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 2.0M | $228.9M | 0.03% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF Invesco Exchange-Traded Fund Trust | 1.8M | $211.3M | 0.22% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list INCY's shares (CUSIP 45337C102), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Dodge & CoxSCHEDULE 13G/A · passive (13G) · 10.1M shares5.0%
Nov 12, 2026 · ↗ - Dodge & CoxSCHEDULE 13G/A · passive (13G) · 12.3M shares6.2%
May 14, 2026 · ↗ - FBB AssociatesSCHEDULE 13D/A · activist (13D) · 33.4K shares0.0%
May 11, 2026 · ↗ - FBB3 LLCSCHEDULE 13D/A · activist (13D) · 31.1K shares0.0%
May 11, 2026 · ↗ - FBB2, LLCSCHEDULE 13D/A · activist (13D) · 14.8K shares0.0%
May 11, 2026 · ↗ - Felix J. BakerSCHEDULE 13D/A · activist (13D) · 31.2M shares15.6%
May 11, 2026 · ↗ - Julian C. BakerSCHEDULE 13D/A · activist (13D) · 31.2M shares15.6%
May 11, 2026 · ↗ - Baker Bros. Advisors (GP) LLCSCHEDULE 13D/A · activist (13D) · 30.9M shares15.4%
May 11, 2026 · ↗ - Baker Bros. Advisors LPSCHEDULE 13D/A · activist (13D) · 30.9M shares15.4%
May 11, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming incyte as client
- AVENUE SOLUTIONSINCYTE CORPORATION · 2026 Q3 · HCR, MMM$60K
Filing ↗ - W STRATEGIES, LLCINCYTE CORPORATION · 2026 Q3 · MMM$60K
Filing ↗ - INCYTE CORPORATIONINCYTE CORPORATION · 2026 Q3 · MMM$380K
Filing ↗ - TIBER CREEK GROUPINCYTE CORPORATION · 2026 Q3 · MMM, HCR$80K
Filing ↗ - LMH STRATEGIC SOLUTIONSINCYTE CORPORATION · 2026 Q2 · HCR, PHA$50K
Filing ↗
Government Contracts
Federal awards to INCYTE CORP · USAspending
No federal contract awards found for INCYTE CORP.
U.S. Patents
Recent USPTO applications naming INCYTE CORP
No USPTO patent applications found for INCYTE CORP.
Annual Financials
From INCY's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B |
| Operating income | $1.51B | $61.4M | $620.5M | $579.4M | $585.8M |
| Net income | $1.29B | $32.6M | $597.6M | $340.7M | $948.6M |
| Diluted EPS | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 |
| Operating cash flow | $1.41B | $335.3M | $496.5M | $969.9M | $749.5M |
| Cash and equivalents | $3.10B | $1.69B | $3.21B | $2.95B | $2.06B |
| Total assets | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B |
| Total liabilities | $1.79B | $2.00B | $1.59B | $1.47B | $1.16B |
| Shareholders' equity | $5.17B | $3.45B | $5.19B | $4.37B | $3.77B |
As INCYTE CORP tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 10, 2026 ↗
Stock Splits
Every split and reverse split in the price history
- 2-for-1Stock splitSep 1, 2000
- 2-for-1Stock splitNov 10, 1997
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 8.01Other eventsNov 13, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsOct 29, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsAug 31, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 28, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJul 6, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsJun 22, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteJun 9, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsJun 8, 2026
EDGAR ↗
About INCYTE CORP
From SEC EDGAR company records
Industry (SIC 8731)Services-Commercial Physical & Biological Research
SectorIndustrials
HeadquartersWILMINGTON, DE
IncorporatedDE
SEC CIK0000879169 ↗
Former namesINCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC


